Optometric Physician


A weekly e-journal by Art Epstein, OD, FAAO

#########

Volume 20, Number 11

Monday, March 9, 2020

#########

Inside this issue: (click heading to view article)
#########
######### Off the Cuff: This. That. And Other Things
#########
######### Continuous Intraocular Pressure Monitoring in Patients with Obstructive Sleep Apnea Syndrome Using a Contact Lens Sensor
#########
######### Central Toxic Keratopathy
#########
######### The Efficacy of Povidone-iodine, Hydrogen Peroxide and a Chemical Multipurpose Contact Lens Care System Against Pseudomonas Aeruginosa on Various Lens Case Surfaces
#########
######### News & Notes
 

Click on the image for upcoming Conferences and Meetings.
http://www.facebook.com/pages/Optometric-Physician/256126944408439

 

Off the Cuff: This. That. And Other Things

If you hadn’t already heard, Vision Expo East was cancelled due to the coronavirus outbreak and combined with Expo West. I was at SECO when the news broke, and while it should not have been unexpected, considering the cancellation of many other large meetings, it still came as a shock to many.

It was hard to tell how much SECO itself was impacted by the outbreak. My flights were fairly empty, and the normally madhouse security area at Atlanta airport at 5pm on Friday was eerily empty. I kept a very low profile since I was nursing a badly tweaked back, but still managed to attend several advisory boards, participate in a few roundtables and deliver two dinner lectures. Looking back, still jetlagged and tired, I don’t know how I managed it.

For me, the highlight of SECO is always the annual Review of Optometry dinner. I’ve not missed one in more years than I can count. What started as a small intimate gathering of Review friends, some industry and respected OD colleagues in the back room of Morton’s, has grown to a gigantic gathering of who’s who in optometry. The tradition was started by Rick Bay, legendary publisher of the Review Group and one of my dearest friends. Rick passed away in December 2012. Eight years later, I still think of him often.

Rick’s best friend and one of my close friends, Jim Henne, took over publishing duties. Jim is the rock that held things together and surprised many of us by announcing his retirement at the dinner. It brought a tear to my eye as the stark realization that an era was coming to an end sank in. Some of you may not realize just how important Review of Optometry has been in the evolution and growth of our profession. A lot of it was because of Rick and Jim working behind the scenes.

Although Jim’s announcement was bittersweet, I was overjoyed seeing Joe Shovlin receive Review’s Frank Fontana Lifetime Achievement Award. Joe has been among the most important clinical minds and leaders in optometry. He is a past chair of the AOA CLCS and served as president of the Academy among many other key roles and achievements. On a personal note Joe was an important role model and largely instrumental in helping me get started. The award was well-deserved.

Finally, a word about the COVID-19 outbreak which will undoubtedly get worse before it gets better. While it is a true public health crisis as infection spreads throughout our communities, panic and irrational behavior are likely to become a growing challenge as this evolves. Some things are becoming increasingly difficult to find so make sure that you have an adequate stock of office essentials including disinfectant, gloves and at least some masks. Recognize that as health care providers, our exposure and risk is probably greater than that of the general public. So be careful, be safe and stay well.




Arthur B. Epstein, OD, FAAO
Chief Medical Editor
artepstein@optometricphysician.com

 

Want to share your perspective? Write to Dr. Epstein at artepstein@optometricphysician.com.

The views expressed in this editorial are solely those of the author and do not necessarily represent the opinions of the editorial board, Jobson Medical Information LLC (JMI), or any other entities or individuals.

 






Advertisement


Continuous Intraocular Pressure Monitoring in Patients with Obstructive Sleep Apnea Syndrome Using a Contact Lens Sensor
 
 

Twenty participants suspected of having obstructive sleep apnea syndrome (OSAS) were recruited to analyze nocturnal intraocular pressure (IOP) fluctuations in patients with OSAS using a contact lens sensor (CLS) and to identify associations between the OSAS parameters determined by polysomnographic study (PSG) and IOP changes. During PSG study, IOP was monitored using a CLS placed in the eye of the patient. The patients were classified according to the apnea-hypopnea index (AHI) in two categories, severe (>30) or mild/moderate (<30) OSAS. Researchers evaluated several parameters determined by the IOP curves, including nocturnal elevations (acrophase) and plateau times in acrophase (PTs) defined by mathematical and visual methods.

The IOP curves exhibited a nocturnal acrophase followed by PTs of varying extent at which the IOP remained higher than daytime measurements with small variations. Researchers found significant differences in the length of the PTs in patients with severe OSAS compared with those with mild/moderate disease. Researchers found a positive correlation between PTs and OSAS severity measured by the total number of apneic events and AHI. Respiratory-related arousal and oxygen saturation also were associated significantly with the IOP PT length.

Periods of nocturnal IOP elevation lasted longer in severe OSAS patients than those with mild/moderate OSAS and correlated with the severity of the disease. The length of the nocturnal PT was also associated with respiratory parameters altered in patients with OSAS.


SOURCE: Carnero E, Bragard J, Urrestarazu E, et al. Continuous intraocular pressure monitoring in patients with obstructive sleep apnea syndrome using a contact lens sensor. PLoS One. 2020;15(3):e0229856.



Advertisement


Central Toxic Keratopathy
 
 

Excimer laser ablation is an increasingly popular option for the correction of mild to moderate refractive errors in the United States. It is generally regarded as safe, with an overall annual complication rate of less than 0.8% since 2010.

Central toxic keratopathy (CTK), first described in 1998, has numerous alternative descriptive names including stage IV diffuse lamellar keratitis, central lamellar keratitis, central flap necrosis, central necrosis lamellar inflammation and keratinocyte-induced corneal micro edema (KME). This rare clinical syndrome classically presents as a central or paracentral, amorphous corneal opacification with associated striae, stromal loss and hyperopic shifts that usually present within nine days of excimer laser ablation (i.e., laser-assisted keratomileusis (LASIK) or photorefractive keratopathy [PRK]). It is believed to be non-inflammatory, but its cause is still unknown.

Though initially thought of as a progression, or severe form, of diffuse lamellar keratitis (DLK), there is significant support that CTK is a distinct and separate entity from DLK. In addition to cases in other refractive surgeries, there are proposals that CTK exists as an entity outside of the refractive surgery literature. There have been reports of CTK associated with contact lens use with and without recent mechanical debridement, idiopathically, as well as potentially with selective laser trabeculoplasty or topical anesthetic use.


SOURCE: Moshirfar M, Hastings J, Ronquillo Y, et al. Central toxic keratopathy. SourceStatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020; Feb. 21.

 

 

The Efficacy of Povidone-iodine, Hydrogen Peroxide and a Chemical Multipurpose Contact Lens Care System Against Pseudomonas Aeruginosa on Various Lens Case Surfaces
 
 

These researchers evaluated the antimicrobial efficacy of a povidone-iodine system (PVP-I; cleadew, OPHTECS), a peroxide system (AOSEPT Plus with HydraGlyde, Alcon), and a chemical multipurpose system (renu fresh, Bausch & Lomb) on contact lens case surfaces that are both in contact and not in contact with the solutions during lens disinfection. The surfaces of the inner walls, underside of the lid, and lens holder (if applicable) of the cases were inoculated with P. aeruginosa ATCC 27853. The cases were disinfected with the solutions as per their manufacturer instructions. After disinfection, the inoculated surfaces were swabbed and the amount of surviving P. aeruginosa was determined. Following this experiment, separate cases were inoculated and disinfected as before. This time the cases were agitated after recommended disinfection time and the amount of P. aeruginosa in the disinfecting solution was quantified immediately, and again after resting for seven days. Experiments were conducted in triplicate (n=3).

Units were expressed in log CFU. All three solutions significantly reduced P. aeruginosa on direct-contact surfaces. On non-contact surfaces, the reduction of P. aeruginosa in the PVP-I system (pre-disinfection: 6.8 ± 0.5, post-disinfection: 1.0 ± 0.0) was significant, but not for the hydrogen peroxide system (pre-disinfection: 6.3 ± 0.6, post: 5.5 ± 0.5) and the chemical multipurpose system (pre-disinfection: 6.6 ± 0.1, post-disinfection: 5.6 ± 0.8). After seven days post-disinfection, no P. aeruginosa regrowth was observed in the PVP-I system (Day 1: 1.0 ± 0.0, Day 7: 1.0 ± 0.0) and the chemical multipurpose system (Day 1: 4.2 ± 0.2, Day 7: 1.8 ± 0.9); however, regrowth was observed in the hydrogen peroxide system (Day 1: 3.4 ± 0.6, Day 7: 6.1 ± 0.4).

The PVP-I system was more effective against P. aeruginosa on non-contact surfaces than the hydrogen peroxide system or the chemical multipurpose system and was capable of inhibiting regrowth of P. aeruginosa for at least seven days post-disinfection.


SOURCE: Yamasaki K, Mizuno Y, Kitamura Y, et al. The efficacy of povidone-iodine, hydrogen peroxide and a chemical multipurpose contact lens care system against Pseudomonas aeruginosa on various lens case surfaces. Cont Lens Anterior Eye. 2020; Feb 27. [Epub ahead of print].





News & Notes
 
SECO 20/20 Announces 20/20 Award Winners
SECO International announced the recipients of its 20/20 awards. These five individuals are being recognized as leaders in optometry and for their significant contributions to the profession.
Southern Council of Optometrists’ President’s Award: Freddie Mayes, OD, of Central City, KY
Southern Council of Optometrists’ Distinguished Service Award: Len Brown, OD, of Fort Myers, FL
Southern Council of Optometrists’ Optometrist of the South Award: Jonathan Shrewsbury, OD, of Beaver Dam, KY
Southern Council of Optometrists’ Young Optometrist of the South Award: Roya Attar, OD, of Madison, MS
Southern Council of Optometrists’ Paraoptometric of the South: Brianna Goodson, CPOA, of Ravenswood, WV
Learn more about SECO.


Menicon America Announces Parameter Expansion for Miru 1month Toric
Menicon America announced a parameter expansion for its Miru 1month Toric lens in the US. This latest addition increases the parameter range by an additional 990 skus and completes a full, round-the-clock toric offering. Miru 1month Toric now offers an axis range of 10° to 180° in 10° increments. The newly added axes are: 30°, 40°, 50°, 60°, 70°, 110°, 120°, 130°, 140° and 150°. Miru 1month Toric is available in three cylinder options, -0.75D, -1.25D and -1.75D, across a power range of Plano to -10.00D. Learn more.


Eyevance Launches Tobradex ST in US
Eyevance Pharmaceuticals announced the US launch of Tobradex ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05% following the company’s acquisition of the product in late 2019. Tobradex ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05% is an FDA- approved, fixed-dose topical antibiotic and corticosteroid combination indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. A next-generation product, Tobradex ST includes a Suspension Technology formulated with pharmaceutical grade xanthan gum, an inactive ingredient designed to stabilize the combination, and enable greater delivery and ocular surface retention of tobramycin and dexamethasone to the eye. Eyevance has branded this unique ST delivery technology, now known as XanGen. Read more.


B+L Launches Get Your Fit Together Music Video for Fitting Success
As part of a continuous effort to meet the diverse needs of patients, Bausch + Lomb launched the Get Your Fit Together music video, developed by eyecare professionals to be an educational and engaging walkthrough of how to have the best success in fitting Ultra Multifocal for Astigmatism contact lenses for some of the hardest to fit patients. A copy of the fitting guide can also be found in the YouTube description. View the video.


Review of Myopia Management: Recommendations for Tapering Long-Term Usage of Topical Low-Dose Atropine
The objective of myopia management is to slow the rate of myopia progression significantly, preferably by 50 percent or more per year. That would achieve the goal of substantially reducing the prevalence of high myopia (-5.00D or greater) by up to 90 percent. To date, topical application of atropine is the only evidence-based drug found effective for myopia management. In comparison to 1 percent (high dose) atropine, low dose atropine is advantageous as there are reduced side effects (photophobia and near blur) while maintaining effective myopia control. Furthermore, the use of topical low-dose atropine for myopia control in children is beginning to be widely adopted after positive results from large scale trials (ATOM2 and LAMP studies) as well as some real-world studies. Read more.


ImprimisRx Announces Supply Agreement with VCNA
ImprimisRx agreed to a product supply agreement with Vision Center Network of America. The agreement will make ImprimisRx a VCNA preferred provider for a variety of surgical formulations, including a portfolio of topical and injectable products. VCNA is a clinically integrated network of ophthalmic ambulatory surgery centers currently serving patients primarily in the New York and New Jersey area. Through the use of its proprietary database, VCNA tracks purchasing volume and patterns for surgical injectables and other products for each of its member surgery centers, specifically as it relates to cataract surgery. Read more.


IDOC Reports Record Conference Attendance
This year’s IDOC National Conference, The Connection 2020, attracted more than 725 IDOC members, sponsor representatives and other industry professionals, the largest gathering in IDOC’s 20-year history. The IDOC optometric alliance provides customized business and practice services to more than 3,000 optometrists. The prevailing theme for this year’s conference was the growing importance of metrics as a vital practice management tool and a key differentiator in an increasingly competitive marketplace. Learn more.


 






Optometric Physician™ Editorial Board
 

Chief Medical Editor
Arthur B. Epstein, OD, FAAO

Journal Reviews
Shannon Steinhäuser, OD, FAAO


Contributing Editors
• Katherine M. Mastrota, MS, OD, FAAO
• Barry A. Weissman, OD, PhD, FAAO (Dip CL)

Editorial Board
• William Jones, OD, FAAO
• Alan G. Kabat, OD, FAAO
• Bruce Onofrey, RPh, OD, FAAO
• John Schachet, OD, FIOS
• Joseph Shovlin, OD, FAAO


 

 

Optometric Physician™ (OP) newsletter is owned and published by Dr. Arthur Epstein. It is distributed by the Review Group, a Division of Jobson Medical Information LLC (JMI), 19 Campus Boulevard, Newtown Square, PA 19073.

To change your email address, reply to this email. Write "change of address" in the subject line. Make sure to provide us with your old and new address.

To ensure delivery, please be sure to add Optometricphysician@jobsonmail.com to your address book or safe senders list.

Click here if you do not want to receive future emails from Optometric Physician.

HOW TO SUBMIT NEWS
E-mail optometricphysician@jobson.com or FAX your news to: 610.492.1039.

HOW TO ADVERTISE
For information on advertising in this e-mail newsletter or other creative advertising opportunities with Optometric Physician, please click here for advertising information.